Malcolm Skingle's guest appearances

Malcolm Skingle

Research 2030

UIDP Conversations

colliderscope 

Judson Brewer

Matt Ridley

Lee Cronin

Eric Corey Freed

David Reed

Ned Calder

Chris Austin

Jennifer Thomson

Doug Maughan

Michael Oakes

Andrew Hamilton

Clint Penick

Jean-Claude Burgelman

Lesley Thompson

Tony Boccanfusos

OwlTail

Malcolm Skingle from Glaxo Smith-Kline tells Sean about the huge opportunities within industry-academia collaborations to drive science for the greater good. Prof Malcolm Skingle manages academic liaison at Glaxo Smith-Kline and faces the challenge of collaborating with people across disciplines and borders, but also bridging academia and industry. Malcolm describes the challenges and opportunities of bringing these diverse groups together and highlights the importance of ensuring that everyone involved benefits from the collaboration. Developed in partnership with Science. Listen now

Malcolm Skingle from Glaxo Smith-Kline tells Sean about the huge opportunities within industry-academia collaborations to drive science for the greater good. Prof Malcolm Skingle manages academic liaison at Glaxo Smith-Kline and faces the challenge of collaborating with people across disciplines and borders, but also bridging academia and industry. Malcolm describes the challenges and opportunities of bringing these diverse groups together and highlights the importance of ensuring that everyone involved benefits from the collaboration. Developed in partnership with Science. Listen now

Episode 3 with Prof. Malcolm Skingle

Collaboration between industry and academia – it’s a topic that divides many scientists. For every researcher eager to embark on a new partnership with a corporate, there’s another hesitant to commit. But with public funding tight, and the issues that face society growing in complexity and urgency, the importance of these collaborations is increasing.This episode features GlaxoSmithKline’s Director of Academic Liaison, Malcolm Skingle, who has more than 20 years’ experience working on these collaborations. With the help of old friend and Elsevier Vice President of Academic Relations, Lesley Thompson, he explores:The benefits these partnerships bring – to both industry and universities/researchers.Some of the “myths” surrounding collaborations, from industry being anti-open science to suppressing researcher publications.The key questions universities should ask before signing on the dotted line.Featured in this episode (Link to full show notes here) Professor Malcolm Skingle Director of Academic Liaison at GlaxoSmithKline and guest speakerMalcolm has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry for over 40 years and gained a wide breadth of experience in the management of research activities. He coordinates Academic Liaison at GSK, managing staff in the US and UK. He sits on many external bodies, including the REF2021 Main Panel A and the BBSRC Council, and chairs several groups. Malcolm was awarded a CBE in 2009 in recognition of his contribution to the pharmaceutical industry. He has also been awarded an Honorary Professorship from the University of Birmingham and an honorary DSc from the University of Hertfordshire. Malcolm was elected a Fellow of the Faculty of Medicine at Imperial College London in 2011 and an honorary fellow of the British Pharmacological Society in 2020 Lesley Thompson, PhDVice President Academic Relations at Elsevier and guest host Lesley joined Elsevier in 2016 as Director Academic &amp; Government Strategic Alliance in the UK. Previously, she worked for 26 years at the Engineering and Physical Sciences Research Council (EPSRC), the largest of the UK’s seven research councils. At Elsevier, Lesley plays a leading role in advancing Elsevier’s initiatives to help universities, funding bodies and governments achieve their strategic objectives. She is a member of the Royal Society Diversity group, and, in January 2016, was awarded an MBE for services to research. Lesley has a PhD in Biology from the University of Essex and is married with children.Giacomo Mancini, PhD Business Development Manager at Elsevier and lead host of the Research 2030 podcastGiacomo is a Business Development Manager at Elsevier and lead host of Elsevier’s Research 2030 podcast series. He received his PhD in Developmental and Evolutionary Biology from New York University and has a vast amount of research experience, having held positions as a Scientist and Research Associate at Johnson &amp; Johnson and Mount Sinai Innovative Partners. While he’s passionate about analytics and bibliometrics, you may also find him reading the sports section of fivethirtyeight.com or tracking MLB player statistics on baseballreference.com. Go Mets!

Collaboration between industry and academia – it’s a topic that divides many scientists. For every researcher eager to embark on a new partnership with a corporate, there’s another hesitant to commit. But with public funding tight, and the issues that face society growing in complexity and urgency, the importance of these collaborations is increasing.This episode features GlaxoSmithKline’s Director of Academic Liaison, Malcolm Skingle, who has more than 20 years’ experience working on these collaborations. With the help of old friend and Elsevier Vice President of Academic Relations, Lesley Thompson, he explores:<ul><li>The benefits these partnerships bring – to both industry and universities/researchers.</li><li>Some of the “myths” surrounding collaborations, from industry being anti-open science to suppressing researcher publications.</li><li>The key questions universities should ask before signing on the dotted line.</li></ul>Featured in this episode <a href="https://www.elsevier.com/research-intelligence/collaboration-between-industry-and-academia" rel="nofollow" target="_blank">(Link to full show notes here)</a> Professor Malcolm Skingle Director of Academic Liaison at GlaxoSmithKline and guest speakerMalcolm has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry for over 40 years and gained a wide breadth of experience in the management of research activities. He coordinates Academic Liaison at GSK, managing staff in the US and UK. He sits on many external bodies, including the REF2021 Main Panel A and the BBSRC Council, and chairs several groups. Malcolm was awarded a CBE in 2009 in recognition of his contribution to the pharmaceutical industry. He has also been awarded an Honorary Professorship from the University of Birmingham and an honorary DSc from the University of Hertfordshire. Malcolm was elected a Fellow of the Faculty of Medicine at Imperial College London in 2011 and an honorary fellow of the British Pharmacological Society in 2020 Lesley Thompson, PhD Vice President Academic Relations at Elsevier and guest host Lesley joined Elsevier in 2016 as Director Academic &amp; Government Strategic Alliance in the UK. Previously, she worked for 26 years at the Engineering and Physical Sciences Research Council (EPSRC), the largest of the UK’s seven research councils. At Elsevier, Lesley plays a leading role in advancing Elsevier’s initiatives to help universities, funding bodies and governments achieve their strategic objectives. She is a member of the Royal Society Diversity group, and, in January 2016, was awarded an MBE for services to research. Lesley has a PhD in Biology from the University of Essex and is married with children. Giacomo Mancini, PhD Business Development Manager at Elsevier and lead host of the Research 2030 podcastGiacomo is a Business Development Manager at Elsevier and lead host of Elsevier’s Research 2030 podcast series. He received his PhD in Developmental and Evolutionary Biology from New York University and has a vast amount of research experience, having held positions as a Scientist and Research Associate at Johnson &amp; Johnson and Mount Sinai Innovative Partners. While he’s passionate about analytics and bibliometrics, you may also find him reading the sports section of <a href="http://fivethirtyeight.com" rel="nofollow" target="_blank">fivethirtyeight.com</a> or tracking MLB player statistics on <a href="http://baseballreference.com" rel="nofollow" target="_blank">baseballreference.com</a>. Go Mets!

Collaboration between industry and academia: Malcolm Skingle GSK’s Director of Academic Liaison

Malcolm Skingle, GlaxoSmithKline's director, academic liaison, discusses the critical role of industry-academic collaboration to address the world's big scientific challenges and what it takes for industry-academic collaborations to succeed.

Malcolm Skingle, GSK, on the elements of successful industry-academic collaboration